z-logo
Premium
Programmed cell death ligand‐1 and cytotoxic T cell infiltrates in metastatic cutaneous squamous cell carcinoma of the head and neck
Author(s) -
Kraft Stefan,
Gadkaree Shekhar K.,
Deschler Daniel G.,
Lin Derrick T.,
Hoang Mai P.,
Emerick Kevin S.
Publication year - 2020
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26370
Subject(s) - cytotoxic t cell , cd8 , medicine , head and neck squamous cell carcinoma , cancer research , cell , lymph node , pathology , t cell , biology , immunology , antigen , immune system , cancer , head and neck cancer , in vitro , biochemistry , genetics
Background Metastatic cutaneous squamous cell carcinoma (cSCC) carries a poor prognosis. Increased numbers of CD8+ cytotoxic T cells are associated with a favorable prognosis and programmed cell death receptor‐1 is a suppressor of the CD8+ cytotoxic T cell response. We aim to define their expression in metastatic cutaneous squamous cell carcinoma. Methods Cytotoxic T cell infiltrates and tumoral PD‐L1 expression in lymph node metastases from patients with cSCC of the head and neck were analyzed. Results High tumoral PD‐L1 expression, intratumoral and peritumoral CD8+ cell density in metastases were significantly associated with poor primary tumor differentiation. Low PD‐L1 expression, intratumoral and peritumoral CD8+ density were associated with lower grade primary tumor differentiation. Low PD‐L1 expression correlated with disease progression. Conclusions Increased expression of PD‐L1 correlates with increased CD8+ cell density. Increased expression of PD‐L1 in poorly differentiated tumors may be more likely to benefit from anti PD‐1/PD‐L1 therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom